Search research articles
Contact Us
Filters
Showing results (121-130 of 157) with videos related to
Page
of 16
Sort By:
NPJ Vaccines
|
November 30, 2022
Non-human primate to human immunobridging demonstrates a protective effect of Ad26.ZEBOV, MVA-BN-Filo vaccine against Ebola
Viki Bockstal, Maarten Leyssen, Dirk Heerwegh, et al.
Nature Communications
|
July 25, 2024
Efficacious human metapneumovirus vaccine based on AI-guided engineering of a closed prefusion trimer
Mark J G Bakkers, Tina Ritschel, Machteld Tiemessen, et al.
Frontiers in Immunology
|
September 20, 2023
Persistence of immunological memory as a potential correlate of long-term, vaccine-induced protection against Ebola virus disease in humans
Chelsea McLean, Karin Dijkman, Auguste Gaddah, et al.
Plos Pathogens
|
April 1, 2016
Cold-Adapted Viral Attenuation (CAVA): Highly Temperature Sensitive Polioviruses as Novel Vaccine Strains for a Next Generation Inactivated Poliovirus Vaccine
Barbara P Sanders, Isabel de Los Rios Oakes, Vladimir van Hoek, et al.
Journal of Virology
|
March 28, 2008
Contribution of CD8+ T cells to containment of viral replication and emergence of mutations in Mamu-A*01-restricted epitopes in Simian immunodeficiency virus-infected rhesus monkeys
Eun-Young Kim, Ronald S Veazey, Roland Zahn, et al.
The New England Journal of Medicine
|
February 11, 2026
Adenoviral Inciting Antigen and Somatic Hypermutation in VITT
Jing Jing Wang, Linda Schönborn, Theodore E Warkentin, et al.
Blood
|
November 17, 2023
Characterization of reverse-engineered anti-PF4 stereotypic antibodies derived from serum of patients with VITT
Jing Jing Wang, Marijn van der Neut Kolfschoten, Lucy Rutten, et al.
Plos One
|
February 21, 2018
A prophylactic multivalent vaccine against different filovirus species is immunogenic and provides protection from lethal infections with Ebolavirus and Marburgvirus species in non-human primates
Benoit Callendret, Jort Vellinga, Kerstin Wunderlich, et al.
Plos One
|
April 25, 2018
Correction: A prophylactic multivalent vaccine against different filovirus species is immunogenic and provides protection from lethal infections with Ebolavirus and Marburgvirus species in non-human primates
Benoit Callendret, Jort Vellinga, Kerstin Wunderlich, et al.
Scientific Reports
|
March 8, 2024
Impact of SARS-CoV-2 spike stability and RBD exposure on antigenicity and immunogenicity
Lucy Rutten, Maarten Swart, Annemart Koornneef, et al.
Page
of 16
Search research articles
Search
Showing results (121-130 of 157) with videos related to
Sort By:
Page
of 16
NPJ Vaccines
|
November 30, 2022
Non-human primate to human immunobridging demonstrates a protective effect of Ad26.ZEBOV, MVA-BN-Filo vaccine against Ebola
Viki Bockstal, Maarten Leyssen, Dirk Heerwegh, et al.
Nature Communications
|
July 25, 2024
Efficacious human metapneumovirus vaccine based on AI-guided engineering of a closed prefusion trimer
Mark J G Bakkers, Tina Ritschel, Machteld Tiemessen, et al.
Frontiers in Immunology
|
September 20, 2023
Persistence of immunological memory as a potential correlate of long-term, vaccine-induced protection against Ebola virus disease in humans
Chelsea McLean, Karin Dijkman, Auguste Gaddah, et al.
Plos Pathogens
|
April 1, 2016
Cold-Adapted Viral Attenuation (CAVA): Highly Temperature Sensitive Polioviruses as Novel Vaccine Strains for a Next Generation Inactivated Poliovirus Vaccine
Barbara P Sanders, Isabel de Los Rios Oakes, Vladimir van Hoek, et al.
Journal of Virology
|
March 28, 2008
Contribution of CD8+ T cells to containment of viral replication and emergence of mutations in Mamu-A*01-restricted epitopes in Simian immunodeficiency virus-infected rhesus monkeys
Eun-Young Kim, Ronald S Veazey, Roland Zahn, et al.
The New England Journal of Medicine
|
February 11, 2026
Adenoviral Inciting Antigen and Somatic Hypermutation in VITT
Jing Jing Wang, Linda Schönborn, Theodore E Warkentin, et al.
Blood
|
November 17, 2023
Characterization of reverse-engineered anti-PF4 stereotypic antibodies derived from serum of patients with VITT
Jing Jing Wang, Marijn van der Neut Kolfschoten, Lucy Rutten, et al.
Plos One
|
February 21, 2018
A prophylactic multivalent vaccine against different filovirus species is immunogenic and provides protection from lethal infections with Ebolavirus and Marburgvirus species in non-human primates
Benoit Callendret, Jort Vellinga, Kerstin Wunderlich, et al.
Plos One
|
April 25, 2018
Correction: A prophylactic multivalent vaccine against different filovirus species is immunogenic and provides protection from lethal infections with Ebolavirus and Marburgvirus species in non-human primates
Benoit Callendret, Jort Vellinga, Kerstin Wunderlich, et al.
Scientific Reports
|
March 8, 2024
Impact of SARS-CoV-2 spike stability and RBD exposure on antigenicity and immunogenicity
Lucy Rutten, Maarten Swart, Annemart Koornneef, et al.
Page
of 16